4
Changes in Ownership
International Stem Cell CORP Filed Acc 0001019687-16-005597
Options or other derivatives
- Chief Financial Officer acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Ebrahimi Mahnaz · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-03-24 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | −20,000 | $3.75 | 2016-03-24 | 20,000 | 20,000 | D |
Loading xslF345X03/ebrahimi_f4-032416.xml…